Advanced company searchLink opens in new window

ABBOTT ASIA INVESTMENTS LIMITED

Company number 05556000

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Jul 2024 AA Full accounts made up to 31 December 2023
23 Nov 2023 CS01 Confirmation statement made on 21 November 2023 with no updates
25 Oct 2023 AP01 Appointment of Mrs Alison Elizabeth Davies as a director on 15 October 2023
25 Oct 2023 TM01 Termination of appointment of John Arthur Mccoy as a director on 15 October 2023
24 Aug 2023 AA Full accounts made up to 31 December 2022
18 Apr 2023 AD02 Register inspection address has been changed from 7 Albemarle Street London W1S 4HQ England to Abbott Uk, Sovereign House 1-2 Bingham Road Sittingbourne Kent ME10 3SU
18 Apr 2023 AD03 Register(s) moved to registered inspection location 7 Albemarle Street London W1S 4HQ
16 Dec 2022 SH01 Statement of capital following an allotment of shares on 15 December 2022
  • GBP 1,358,256,035
15 Dec 2022 SH19 Statement of capital on 15 December 2022
  • GBP 110,035
15 Dec 2022 SH20 Statement by Directors
15 Dec 2022 CAP-SS Solvency Statement dated 15/12/22
15 Dec 2022 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
28 Nov 2022 CS01 Confirmation statement made on 21 November 2022 with no updates
31 Oct 2022 AD02 Register inspection address has been changed from C/O Abbott Sovereign House 1-2 Bingham Road Sittingbourne Kent ME10 3SU United Kingdom to 7 Albemarle Street London W1S 4HQ
09 Aug 2022 AA Full accounts made up to 31 December 2021
22 Nov 2021 CS01 Confirmation statement made on 21 November 2021 with no updates
01 Oct 2021 AA Full accounts made up to 31 December 2020
23 Mar 2021 AP01 Appointment of John Arthur Mccoy as a director on 22 March 2021
23 Mar 2021 TM01 Termination of appointment of Karen Marie Peterson as a director on 22 March 2021
23 Dec 2020 CS01 Confirmation statement made on 21 November 2020 with no updates
23 Dec 2020 PSC07 Cessation of Abbott Laboratories Inc. as a person with significant control on 16 April 2016
07 Oct 2020 AA Full accounts made up to 31 December 2019
06 May 2020 AP01 Appointment of Mr Michael Robert Kendall Clayton as a director on 23 March 2020
05 May 2020 TM01 Termination of appointment of Georgios Mountrichas as a director on 23 March 2020
11 Mar 2020 AP01 Appointment of Karen Marie Peterson as a director on 1 March 2020